358 related articles for article (PubMed ID: 27736770)
1. Design and Validation of Novel Chikungunya Virus Protease Inhibitors.
Das PK; Puusepp L; Varghese FS; Utt A; Ahola T; Kananovich DG; Lopp M; Merits A; Karelson M
Antimicrob Agents Chemother; 2016 Dec; 60(12):7382-7395. PubMed ID: 27736770
[TBL] [Abstract][Full Text] [Related]
2. Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease's active site cysteine residue.
Rausalu K; Utt A; Quirin T; Varghese FS; Žusinaite E; Das PK; Ahola T; Merits A
Sci Rep; 2016 Nov; 6():37124. PubMed ID: 27845418
[TBL] [Abstract][Full Text] [Related]
3. Interdomain Flexibility of Chikungunya Virus nsP2 Helicase-Protease Differentially Influences Viral RNA Replication and Infectivity.
Law YS; Wang S; Tan YB; Shih O; Utt A; Goh WY; Lian BJ; Chen MW; Jeng US; Merits A; Luo D
J Virol; 2021 Feb; 95(6):. PubMed ID: 33328310
[TBL] [Abstract][Full Text] [Related]
4. Conformer and pharmacophore based identification of peptidomimetic inhibitors of chikungunya virus nsP2 protease.
Dhindwal S; Kesari P; Singh H; Kumar P; Tomar S
J Biomol Struct Dyn; 2017 Dec; 35(16):3522-3539. PubMed ID: 27844505
[TBL] [Abstract][Full Text] [Related]
5. Mutations conferring a noncytotoxic phenotype on chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2.
Utt A; Das PK; Varjak M; Lulla V; Lulla A; Merits A
J Virol; 2015 Mar; 89(6):3145-62. PubMed ID: 25552719
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.
El-labbad EM; Ismail MA; Abou Ei Ella DA; Ahmed M; Wang F; Barakat KH; Abouzid KA
Chem Biol Drug Des; 2015 Dec; 86(6):1518-27. PubMed ID: 26212366
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of chikungunya virus nsP2 cysteine protease reveals a putative flexible loop blocking its active site.
Narwal M; Singh H; Pratap S; Malik A; Kuhn RJ; Kumar P; Tomar S
Int J Biol Macromol; 2018 Sep; 116():451-462. PubMed ID: 29730006
[TBL] [Abstract][Full Text] [Related]
8. Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents.
Jadav SS; Sinha BN; Hilgenfeld R; Jayaprakash V
Curr Comput Aided Drug Des; 2017 Nov; 13(4):346-361. PubMed ID: 28294048
[TBL] [Abstract][Full Text] [Related]
9. Identification of chikungunya virus nsP2 protease inhibitors using structure-base approaches.
Nguyen PT; Yu H; Keller PA
J Mol Graph Model; 2015 Apr; 57():1-8. PubMed ID: 25622129
[TBL] [Abstract][Full Text] [Related]
10. The Methyltransferase-Like Domain of Chikungunya Virus nsP2 Inhibits the Interferon Response by Promoting the Nuclear Export of STAT1.
Göertz GP; McNally KL; Robertson SJ; Best SM; Pijlman GP; Fros JJ
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925658
[TBL] [Abstract][Full Text] [Related]
11. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
12. Chikungunya virus inhibition by peptidomimetic inhibitors targeting virus-specific cysteine protease.
Singh H; Mudgal R; Narwal M; Kaur R; Singh VA; Malik A; Chaudhary M; Tomar S
Biochimie; 2018 Jun; 149():51-61. PubMed ID: 29635044
[TBL] [Abstract][Full Text] [Related]
13. A Chikungunya Virus
Bartholomeeusen K; Utt A; Coppens S; Rausalu K; Vereecken K; Ariën KK; Merits A
J Virol; 2018 Jul; 92(14):. PubMed ID: 29695432
[TBL] [Abstract][Full Text] [Related]
14. Semliki Forest Virus Chimeras with Functional Replicase Modules from Related Alphaviruses Survive by Adaptive Mutations in Functionally Important Hot Spots.
Teppor M; Žusinaite E; Karo-Astover L; Omler A; Rausalu K; Lulla V; Lulla A; Merits A
J Virol; 2021 Sep; 95(20):e0097321. PubMed ID: 34319778
[TBL] [Abstract][Full Text] [Related]
15. Full length and protease domain activity of chikungunya virus nsP2 differ from other alphavirus nsP2 proteases in recognition of small peptide substrates.
Saisawang C; Sillapee P; Sinsirimongkol K; Ubol S; Smith DR; Ketterman AJ
Biosci Rep; 2015 Apr; 35(3):. PubMed ID: 26182358
[TBL] [Abstract][Full Text] [Related]
16. Viral Polymerase-Helicase Complexes Regulate Replication Fidelity To Overcome Intracellular Nucleotide Depletion.
Stapleford KA; Rozen-Gagnon K; Das PK; Saul S; Poirier EZ; Blanc H; Vidalain PO; Merits A; Vignuzzi M
J Virol; 2015 Nov; 89(22):11233-44. PubMed ID: 26311883
[TBL] [Abstract][Full Text] [Related]
17. Functional cross-talk between distant domains of chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity.
Das PK; Merits A; Lulla A
J Biol Chem; 2014 Feb; 289(9):5635-53. PubMed ID: 24407286
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationship of Chikungunya nsP2 protease: A comparative study with papain.
Ramakrishnan C; Kutumbarao NHV; Suhitha S; Velmurugan D
Chem Biol Drug Des; 2017 May; 89(5):772-782. PubMed ID: 28054451
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-Conjugating Enzyme E2 L3 is Downregulated by the Chikungunya Virus nsP2 Protease.
Ramphan S; Khongwichit S; Saisawang C; Kovanich D; Ketterman AJ; Ubol S; Auewarakul P; Roytrakul S; Smith DR; Kuadkitkan A
Proteomics Clin Appl; 2018 Jul; 12(4):e1700020. PubMed ID: 28975709
[TBL] [Abstract][Full Text] [Related]
20. Development of nsP2 protease based cell free high throughput screening assay for evaluation of inhibitors against emerging Chikungunya virus.
Saha A; Acharya BN; Priya R; Tripathi NK; Shrivastava A; Rao MK; Kesari P; Narwal M; Tomar S; Bhagyawant SS; Parida M; Dash PK
Sci Rep; 2018 Jul; 8(1):10831. PubMed ID: 30018455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
